RecruitingNot Applicable

Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.

Colombia62 participantsStarted 2023-08-01

Plain-language summary

The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients ≥ 18 years.
✓. Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.
✓. Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma according to the Bethesda criteria)
✓. Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.
✓. Patients requiring or not requiring thyroidectomy and/or central dissection concomitant with the dissection

Exclusion criteria

✕. Patients with a history of previous neck dissection
✕. Histological confirmation of medullary or anaplastic carcinoma
✕. Previous spinal nerve injury

What they're measuring

Shoulder dysfunction

Timeframe: 2 weeks, 3 months, 6 months, and 1 year

Cervical disconfort

Timeframe: 2 weeks, 3 months, 6 months, and 1 year

Complications

Timeframe: 30 days

Trial details

NCT IDNCT06149637

SponsorCentro de Excelencia en Enfermedades de Cabeza y Cuello

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

Contact for this trial

Alvaro Sanabria, MD

3138175170 alvarosanabria@gmail.com

View on ClinicalTrials.gov More Thyroid Cancer trials